Pyxis Oncology, Inc
Clinical trials sponsored by Pyxis Oncology, Inc, explained in plain language.
-
New cancer drug enters first human trials
Disease control Recruiting nowThis is the first study in people testing a new drug called PYX-201 for advanced solid tumors that have spread or returned after other treatments. The main goals are to find a safe dose and see if the drug can shrink tumors. The study will enroll about 330 adults with specific ty…
Phase: PHASE1 • Sponsor: Pyxis Oncology, Inc • Aim: Disease control
Last updated Apr 04, 2026 05:06 UTC
-
New Two-Drug combo enters human testing for tough cancers
Disease control Recruiting nowThis early-stage study is testing a new drug called PYX-201 in combination with an existing immunotherapy (pembrolizumab) for people with advanced solid tumors. The main goals are to find the safest and most effective dose and to see how well the body handles the two drugs togeth…
Phase: PHASE1, PHASE2 • Sponsor: Pyxis Oncology, Inc • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC